MedPath

Ammonia N 13

These highlights do not include all the information needed to use Ammonia N 13 Injection, USP safely and effectively. See full prescribing information for Ammonia N 13 Injection, USP. Ammonia N 13 Injection, USP for intravenous useInitial U.S. Approval: 2007

Approved
Approval ID

a4a2bb1a-1ecc-48e4-a87b-60fc583f61ce

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 6, 2023

Manufacturers
FDA

Biomedical Research Foundation of Northwest Louisiana

DUNS: 184750008

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ammonia N-13

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code24562-004
Application NumberANDA204352
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ammonia N-13
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 12, 2015
FDA Product Classification

INGREDIENTS (2)

Sodium ChlorideInactive
Quantity: 0.9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
Ammonia N-13Active
Quantity: 37.5 mCi in 1 mL
Code: 9OQO0E343Z
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ammonia N 13 - FDA Drug Approval Details